Investment in Minnetronix

New York, NY: Altaris Capital Partners, LLC announces an investment in Minnetronix, Inc.
Minnetronix provides design, development and manufacturing services to the medical technology industry. The Company is also leveraging its engineering expertise to develop a platform of proprietary technologies that possess clinical breakthrough potential. Altaris is partnering with the Minnetronix management team and employees to support the future growth of the Company.
Altaris Capital Partners was advised on this transaction by Piper Jaffray and Schiff Hardin LLP.
About Altaris Capital Partners, LLC
Altaris Capital Partners, LLC is an investment firm focused exclusively on the healthcare industry. Managing $1.3 billion of equity capital, Altaris invests in businesses that meet clearly defined healthcare needs and leverages its extensive industry knowledge and relationships to accelerate growth and value appreciation. Altaris is based in New York, NY.
About Minnetronix, Inc.
Minnetronix is a medical technology and innovation company with deep expertise in electronic and electromechanical devices. Founded in 1996, the company creates new technologies and therapies that solve unmet clinical and business needs for patients and medical device companies. Minnetronix is FDA Registered and ISO 13485 Certified.